Rely on Worldwide to Run Your Pancreatic Cancer Therapy Study
Pancreatic cancer develops quickly and is difficult to detect. By the time it is discovered, it is well-established and may have spread throughout the patient’s body. It is also notoriously difficult to treat with chemotherapy and radiation techniques.
Are you working on tools to improve the early detection of pancreatic cancer? Are you working on a novel therapy to help cure cancer for these patients? Success in either area can combat pancreatic cancer, which kills more than 40,000 people each year.1
But getting your work to market means threading a path through the rigors of clinical trials. That’s where Worldwide Clinical Trials comes in. Worldwide has more than 30 years of experience supporting research in oncology, immune-mediated inflammatory disorders (IMID), and the development of novel therapies. We are internationally acclaimed experts in clinical trial management, offering full-service support for Phase I-Phase IV clinical trials, as well as real-world evidence studies that can help you understand the effects of your work over both the short and long term.
When you need a stable team of project professionals who already have experience in oncology research, turn to Worldwide. Whether you need feedback on development plans, a detailed feasibility analysis, or the resources and management skills to ensure delivery of your project on time and on budget, Worldwide is the CRO that can help.